"10.1371_journal.pone.0123509","plos one","2015-04-09T00:00:00Z","Miguel A Lanaspa; L Elaine Epperson; Nanxing Li; Christina Cicerchi; Gabriela E Garcia; Carlos A Roncal-Jimenez; Jessica Trostel; Swati Jain; Colin T Mant; Christopher J Rivard; Takuji Ishimoto; Michiko Shimada; Laura Gabriela Sanchez-Lozada; Takahiko Nakagawa; Alkesh Jani; Peter Stenvinkel; Sandra L Martin; Richard J Johnson","Division of Renal Diseases and Hypertension, University of Colorado Denver, Aurora, CO, 80045, United States of America; Department of Cell and Developmental Biology, Aurora, CO, 80045, United States of America; Department of Biochemistry and Molecular Genetics, Aurora, CO, 80045, United States of America; Laboratory of Renal Physiopathology and Nephrology Dept, INC Ignacio Chavez, Mexico City, Mexico; Division of Renal Medicine, Department of Clinical Intervention and Technology, Karolinska Institutet, Stockholm, Sweden; Division of Nephrology, Eastern Colorado Health System, Department of Veteran Affairs, Denver, CO, United States of America","Conceived and designed the experiments: MAL LEE GEG MS AJ SLM RJJ. Performed the experiments: MAL LEE NL CC GEG CARJ SJ JT CTM. Analyzed the data: MAL CJR TI LGSL TN PS SLM RJJ JT. Contributed reagents/materials/analysis tools: MAL GEG CR SLM RJJ. Wrote the paper: MAL LEE NL CC SLM RJJ.","Drs MAL, CJR, GEG and RJJ are listed as inventors on a patent for the use of AMPD2 inhibitors to treat obesity and insulin resistance (US 8,697, 628). MAL, CJR, LGSL, CARJ and RJJ are also members of Colorado Research Partners LLC that is interested in developing novel treatments for obesity. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2015","04","Miguel A Lanaspa","MAL",18,TRUE,7,9,9,6,TRUE,TRUE,FALSE,0,NA,FALSE
